+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Travel Vaccine Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 123 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5821714

Specialized travel clinics and health centers have emerged during COVID to cater specifically to the needs of travelers

The Global Travel Vaccines Market is estimated to be USD 4.18 Bn in 2023 and is expected to reach USD 6.64 Bn by 2028 growing at a CAGR of 9.68%.

  • The increased awareness of vaccine-preventable diseases among travelers is significantly driving market growth. The number of cross-border travelers has increased dramatically as a result of globalization. Vaccine-preventable diseases have received considerable attention in recent years. The increased awareness is linked to high vaccine uptake among travelers. Tour organizers are very important in raising awareness about vaccine-preventable diseases.
  • Moreover, Initiatives by governments and other organizations to enhance travel safety are significant trends in the market. The rise in the incidence of travel-related diseases around the world has prompted governments and other organizations to take steps to safeguard the safety of international travel. Many organizations are launching campaigns to promote safe and healthy travel. Worldwide, for example, strives to inform travelers about preventable and non-vaccine preventable diseases. Its web system also provides travel immunization management to healthcare providers. Similarly, Australia's Department of Foreign Affairs and Trade gives current information on diseases prevalent in many countries. Therefore, the growing demand for vaccination and initiatives by government organizations to ensure travel safety are expected to support the market's growth.
  • However, the high cost of travel vaccinations limits the market growth. A typical first-time traveler requires 2-3 immunizations. Travel clinics charge more for immunizations; new vaccines are the most expensive. The high costs restrict travelers from being fully immunized before travel. Furthermore, patients may regard immunizations as unnecessary. Furthermore, the expensive expense of travel immunization may deter students and travelers from seeking immunization.
  • Also, the side effects associated with some vaccines are challenging for the growth of the Global Travel Vaccine Market. The fear of vaccine side effects creates hesitancy in travelers toward vaccines which ultimately makes them avoid getting vaccinated.

Market Segmentations

  • The Global Travel Vaccine Market is segmented based on Disease Type, Booking Channel, Tourist Type, Tour Type, Age Group, and Geography.
  • By Disease Type, the market is classified into Covid-19, Ebola, Influenza, Hepatitis, and Others.
  • Influenza in the past years had the highest share and Covid-19 is growing at the highest CAGR after the pandemic.
  • By Booking Channel, the market is classified into Online Booking and Offline Booking.
  • Online booking channels are growing with the highest CAGR as online booking options become more prevalent due to social distancing measures and the increased adoption of telemedicine services.
  • By Tourist Type, the market is classified into Domestic and International.
  • The International Tourist segment holds the higher market share because international travel often involves visiting countries with different health risks and requirements, necessitating a broader range of vaccines to ensure traveler safety.
  • By Age Group, the market is classified into Children, Adults, and Geriatric. Adults group has the highest market share as they travel the most for work purposes.
  • By Geography, the market is classified into the Americas, Europe, Middle East & Africa, and Asia-Pacific. The Americas hold the highest share as people travel most to this region for work and holiday purposes. In addition, the countries in the Americas region strongly emphasize travel health recommendations and may have a relatively higher consumption of travel vaccines.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Company Abbott, AstraZeneca, Bharat Biotech, Merck, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of the Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Travel Vaccine Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Travel Vaccine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Travel Vaccine Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
  • Excel data sheet for the market size will also be provided with the report.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
  • The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors.
  • The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
  • Market segmentation
  • Competitive Analysis: Comparative analysis of competitor
  • Historical, current, and projected size of the market based on value and volume
  • Market size of the US states
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Impact Analysis
4.2 Drivers
4.2.1 Increasing Awareness of Vaccine-Preventable Diseases
4.2.2 Increasing Travel and Tourism
4.2.3 Rising Prevalence of Life-Threatening Infectious Diseases
4.3 Restraints
4.3.1 High Cost of Vaccines
4.4 Opportunities
4.4.1 Governing and Non-Governing Agencies of Various Countries are Encouraging the Adoption of Travel Vaccines
4.4.2 Technological Advancements, Such as Needle-Free Injection Technology (NFIT)
4.5 Challenges
4.5.1 Side Effects Associated with Vaccines Compiled with Needle Fears and Phobia
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis
6 Global Travel Vaccine Market, By Disease Type
6.1 Introduction
6.2 Covid-19
6.3 Ebola
6.4 Influenza
6.5 Hepatitis
6.6 Others (Polio, Meningococcal, Pneumococcal, MMR)
7 Global Travel Vaccine Market, By Booking Channel
7.1 Introduction
7.2 Online Booking
7.3 Offline Booking
8 Global Travel Vaccine Market, By Tourist Type
8.1 Introduction
8.2 Domestic
8.3 International
9 Global Travel Vaccine Market, By Tour Type
9.1 Introduction
9.2 Independent Traveler
9.3 Tour Group
9.4 Package Traveler
10 Global Travel Vaccine Market, By Age Group
10.1 Introduction
10.2 Children
10.3 Adults
10.4 Geriatric
11 Americas' Travel Vaccine Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe's Travel Vaccine Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Ireland
12.10 Luxembourg
12.11 Netherlands
12.12 Norway
12.13 Poland
12.14 Russia
12.15 Spain
12.16 Sweden
12.17 Switzerland
12.18 United Kingdom
12.19 Rest of Europe
13 Middle East and Africa's Travel Vaccine Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Nigeria
13.6 Saudi Arabia
13.7 South Africa
13.8 United Arab Emirates
13.9 Rest of MEA
14 APAC's Travel Vaccine Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
16 Company Profiles
16.1 Abbott
16.1.1 Company Overview
16.1.2 Company Snapshot
16.1.3 Product Overview
16.1.4 Business Overview
16.1.5 SWOT Analysis
16.1.6 Recent Development
16.2 AstraZeneca
16.2.1 Company Overview
16.2.2 Company Snapshot
16.2.3 Product Overview
16.2.4 Business Overview
16.2.5 SWOT Analysis
16.2.6 Recent Development
16.3 Bausch Health Companies Inc.
16.3.1 Company Overview
16.3.2 Company Snapshot
16.3.3 Product Overview
16.3.4 Business Overview
16.3.5 SWOT Analysis
16.3.6 Recent Development
16.4 Bharat Biotech
16.4.1 Company Overview
16.4.2 Company Snapshot
16.4.3 Product Overview
16.4.4 Business Overview
16.4.5 SWOT Analysis
16.4.6 Recent Development
16.5 BioNTech SE
16.5.1 Company Overview
16.5.2 Company Snapshot
16.5.3 Product Overview
16.5.4 Business Overview
16.5.5 SWOT Analysis
16.5.6 Recent Development
16.6 Dynavax Technologies
16.6.1 Company Overview
16.6.2 Company Snapshot
16.6.3 Product Overview
16.6.4 Business Overview
16.6.5 SWOT Analysis
16.6.6 Recent Development
16.7 Emergent BioSolutions
16.7.1 Company Overview
16.7.2 Company Snapshot
16.7.3 Product Overview
16.7.4 Business Overview
16.7.5 SWOT Analysis
16.7.6 Recent Development
16.8 F. Hoffmann-La Roche Ltd
16.8.1 Company Overview
16.8.2 Company Snapshot
16.8.3 Product Overview
16.8.4 Business Overview
16.8.5 SWOT Analysis
16.8.6 Recent Development
16.9 GSK plc
16.9.1 Company Overview
16.9.2 Company Snapshot
16.9.3 Product Overview
16.9.4 Business Overview
16.9.5 SWOT Analysis
16.9.6 Recent Development
16.10 Merck & Co., Inc.
16.10.1 Company Overview
16.10.2 Company Snapshot
16.10.3 Product Overview
16.10.4 Business Overview
16.10.5 SWOT Analysis
16.10.6 Recent Development
16.11 Moderna, Inc.
16.11.1 Company Overview
16.11.2 Company Snapshot
16.11.3 Product Overview
16.11.4 Business Overview
16.11.5 SWOT Analysis
16.11.6 Recent Development
16.12 Novartis Ag
16.12.1 Company Overview
16.12.2 Company Snapshot
16.12.3 Product Overview
16.12.4 Business Overview
16.12.5 SWOT Analysis
16.12.6 Recent Development
16.13 Pfizer Inc.
16.13.1 Company Overview
16.13.2 Company Snapshot
16.13.3 Product Overview
16.13.4 Business Overview
16.13.5 SWOT Analysis
16.13.6 Recent Development
16.14 Sanofi
16.14.1 Company Overview
16.14.2 Company Snapshot
16.14.3 Product Overview
16.14.4 Business Overview
16.14.5 SWOT Analysis
16.14.6 Recent Development
16.15 Serum Institute of India
16.15.1 Company Overview
16.15.2 Company Snapshot
16.15.3 Product Overview
16.15.4 Business Overview
16.15.5 SWOT Analysis
16.15.6 Recent Development
16.16 Sinovac
16.16.1 Company Overview
16.16.2 Company Snapshot
16.16.3 Product Overview
16.16.4 Business Overview
16.16.5 SWOT Analysis
16.16.6 Recent Development
16.17 Takeda Pharmaceutical Company Ltd.
16.17.1 Company Overview
16.17.2 Company Snapshot
16.17.3 Product Overview
16.17.4 Business Overview
16.17.5 SWOT Analysis
16.17.6 Recent Development
16.18 Valneva SE
16.18.1 Company Overview
16.18.2 Company Snapshot
16.18.3 Product Overview
16.18.4 Business Overview
16.18.5 SWOT Analysis
16.18.6 Recent Development
17 Appendix
17.1 Self-Assessment Form

Companies Mentioned

  • Abbott
  • AstraZeneca
  • Bausch Health Companies Inc.
  • Bharat Biotech
  • BioNTech SE
  • Dynavax Technologies
  • Emergent BioSolutions
  • F. Hoffmann-La Roche Ltd
  • GSK plc.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novartis Ag
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India
  • Sinovac
  • Takeda Pharmaceutical Company Ltd.
  • Valneva SE

Table Information